Micreos Pharmaceuticals

Views & Analysis

Antimicrobial resistance (AMR) is an issue of global concern, killing roughly 1.2 million1 people per year and projected to rise to

News

Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.